You are here
New Studies of Inflammation in Infarcted Hearts Could Lead to Changes in Therapy
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Fundación Jiménez Díaz (FJD) and Salamanca University hospitals in Spain have demonstrated that the response of the human heart to an infarction is very different than what was previously thought. The study, led by cardiologist Borja Ibáñez and published in two independent articles in the journals Circulation and Circulation Research, overturns the established view that an infarction is followed by progressive repair of the myocardium.
For many years, scientists have assumed that a heart attack is followed immediately by an inflammatory response featuring increases in water content and cellular infiltration and that this response remains stable for at least one week and then progressively dissipates. Two years ago, the research team behind the new studies published a series of animal studies that challenged this view, but the most important challenge remained: to validate the findings in human patients.
The new studies used magnetic resonance imaging (MRI) technology to demonstrate that the human heart produces two well-differentiated edematous reactions occurring at distinct times after an infarction. These results have immediate clinical implications for ongoing clinical trials and could form the basis of future studies focused on the specific modulation of each of these independent edematous phases.
Rodrigo Fernández-Jiménez, first author on both studies, explained that “surprisingly, we still know very little about how the myocardium reacts to an infarction, and it is only through the use of MRI, which allows noninvasive, millimeter-resolution mapping of tissue composition, that we are beginning to understand many of its mysteries.”
The bimodal postinfarction inflammatory reaction was first demonstrated in animals in 2015, but this left the much-more-difficult challenge of demonstrating that the same phenomenon occurs in human patients. Undertaking such a study required a special set-up that would allow detailed MRI studies to be carried out immediately after the re-establishment of blood flow through the blocked coronary artery in heart attack patients. This requires highly complex technology and is therefore possible in only a handful of centers in Spain. One center with the technology and expertise to carry out this type of study is the university hospital in Salamanca.
As chief cardiologist Pedro Luis Sánchez explained, “we’ve been able to carry out this work thanks to the enthusiasm and commitment of everyone in the service. Heart attacks can happen at any time of day or night or on weekends, and for this study we needed to do the first MRI scan within three hours of fitting a stent in the blocked artery to re-establish blood flow. Patients are particularly vulnerable during this period, so in addition to the expert MRI specialists, we also needed a full clinical support team on hand to provide continuous care during the examination period.”
The study is the first in the world to study heart attack patients by MRI so soon after the re-establishment of blood flow. “MRI provides an extraordinary ability to noninvasively visualize events occurring after an infarction in real time, including inflammation, tissue volume expansion, hemorrhage, and obstruction of the microcirculation,” Fernández-Jiménez said.
According to Ibáñez, the discovery of the bimodal inflammatory response in the human heart “forces us to think about the best timing for MRI scans used in clinical trials to quantify irreversible injury and to monitor the effectiveness of interventions to reduce this injury. Until now this question was not considered important, and cardiac imaging studies have been conducted on any day in the postinfarction period. The new findings show that the optimal time for these scans is between postinfarction days 4 and 7, when the second inflammatory/edematous wave is prominent and affects the entire region that was shut off from the blood supply during the infarction.”
Source: CNIC; August 22, 2017.